BIO-TECHNE Corp (TECH) › Cost of RevenueBIO-TECHNE Corp (TECH) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2009: $55.92M2010: $54.90M2011: $65.03M2012: $78.76M2013: $79.47M2014: $106.35M2015: $144.97M2016: $162.36M2017: $188.46M2018: $210.85M2019: $240.51M2020: $255.50M2021: $298.18M2022: $349.10M2023: $366.89M2024: $389.33M2025: $429.36M$429.36M2009Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$429.36M+10.3%2024$389.33M+6.1%2023$366.89M+5.1%2022$349.10M+17.1%2021$298.18M+16.7%2020$255.50M+6.2%2019$240.51M+14.1%2018$210.85M+11.9%2017$188.46M+16.1%2016$162.36M+12.0%2015$144.97M+36.3%2014$106.35M+33.8%2013$79.47M+0.9%2012$78.76M+21.1%2011$65.03M+18.4%2010$54.90M-1.8%2009$55.92M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share